Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by 4Justiceon May 15, 2020 2:33pm
401 Views
Post# 31035016

RE:Francois and his 8 month long imminent lawsuit:)

RE:Francois and his 8 month long imminent lawsuit:)Realstocky

I,don,t know who you are and who you,re working to ! I don't mind!

1- There's a lawsuit prepaired by Dunton Rainville and paid by more then 500 frustrated shareolders.
2- There's a second one by licensees who are shocked to se Galbraith abandonimportant and lucrative developpement projects for which they have royalties.
3- The new one will be related to the layoff of Galbraith and his close friend Garry Bridger who bought any share and are proud to announce $240 millions of lost in 2019, $ 30 millions in Q1/ 2020  lay off of great scientifics,sub contracted ngociation with FDA without results and destroy the credibility of sciences behind prometic.

Stay tune body...This company a real bluckbuster, worth today almost nothing by the incompetence and false representation of its management.. whom by the the way never bougt a single share.

Peter Thomson is not stupid. He gona mouve !


<< Previous
Bullboard Posts
Next >>